Clinical updates, including trial initiations, enrollment status and data readouts and publications: Orlucent.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aorticlab, Avanos Medical, Brainomix, Capitan Orthopedics, Emboline, Genesis Innovation, Illumina, Serres, Siemens Healthineers.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott Labs, Cepheid.

The top 10 biopharma stock gainers and losers for the week.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Immunitybio, Saofi.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Amplia Therapeutics, Immunofoco Biotechnology, Lynk Pharmaceuticals, Teva Pharmaceutical Industries.

Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Applied Cells, AFT, Beyond Air, Combinableai, Eisai, Elpasbio, Formosa, Fosun Kairos, Immuneel, Insitro, LG Chem, Neuronos, Novartis, Nuvation, Pacira Biosciences, Samil, SL Bio, Stablepharma, XLT Biopharmaceuticals, Zonsen Peplib Biotech.

Biopharmas in Asia-Pacific raising money in public or private financings: Biofrontera, Ferrer, Hatchtech, Pelthos, Qurient, Vibrant.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Adolore, Eli Lilly, Sanofi, Santhera.

Biopharma happenings, including deals and partnerships, and other news in brief: Agenus, AFT, Alfasigma, Alveus, Eagle, Innovative Molecules, LXO, Stablepharma, Zydus.